Global cardiopulmonary bypass equipment market is estimated to witness high growth, owing to increasing cardiac surgeries & technological advancements
Global Cardiopulmonary Bypass Equipment Market is estimated to be valued at USD 205.1 Mn in 2024, exhibiting a CAGR of 2.6 % over the forecast period 2024-2031. The market growth is driven by factors like rising number of cardiac surgeries performed worldwide and increasing availability of advanced cardiopulmonary bypass equipment. Furthermore, growing prevalence of cardiovascular diseases due to sedentary lifestyles and aging population can boost demand for cardiopulmonary bypass equipment.
Market Dynamics:
Global cardiopulmonary bypass equipment market growth is primarily driven by increasing number of cardiac surgeries performed globally every year. As per recent studies, over 300,000 cardiovascular surgeries are performed annually using cardiopulmonary bypass systems across the world. Rapid technological advancements such as miniaturization of CPB equipment and development of portable systems can drive the market growth during the forecast period. Introduction of advanced equipment with features such as improved oxygenation, biocompatibility, and energy efficiency are expanding the potential applications of CPB systems.
Increasing Prevalence of Cardiovascular Diseases Boosts Demand for Cardiopulmonary Bypass Equipment
Cardiovascular diseases (CVDs) are one of the leading causes of mortality worldwide. According to the World Health Organization, CVDs account for approximately 17.9 million deaths annually. Growing geriatric population prone to CVDs and the sedentary lifestyle adopted by many people, which leads to obesity and other risk factors, can increase prevalence of CVDs. As CVD patients require surgeries like coronary artery bypass grafting (CABG) and various heart surgeries that utilize cardiopulmonary bypass equipment, increasing disease burden has boosted demand for cardiopulmonary bypass equipment. Cardiopulmonary bypass (CPB) is effective in many complex surgeries, thus, boosting adoption of these devices.
Technological Advancements in Cardiopulmonary Bypass Equipment
Cardiopulmonary bypass equipment has evolved significantly over the past few decades due to ongoing R&D investments by leading manufacturers. Newer systems come with advanced features like better blood filters, improved oxygenators, compact designs, touchscreen controls, and integrated components required for surgeries. Such innovations have enabled enhanced safety, shorter setup times, easier operability, and improved clinical outcomes. For instance, advanced pumps can now achieve non-pulsatile blood flow seamlessly. Improved designs minimize coagulation and inflammation during bypass. Many countries are also undergoing healthcare modernization projects, which mandate the utilization of latest medical technology. These factors are encouraging the replacement of aged cardiopulmonary systems with new advanced variants in both developed and developing nations.
Reimbursement Issues and Budgetary
While CVD cases increases, healthcare budgets remain restricted in many countries. Financial constraints compel governments to ration medical device funding and procedures requiring cardiopulmonary equipment often do not get top reimbursement priority. Cardiopulmonary bypass systems are also capital intensive with purchase and maintenance costs running into hundreds of thousands of dollars. Limited coverage policies demotivate hospitals from frequently upgrading to high-end devices. Developing economies also have inadequate allocation for non-communicable diseases like heart disorders. Stringent regulations further delay new product approval and market entry. Patients in such regions lack reliable access to cardiopulmonary devices, thus, hampering the market growth.
Shortage of Skilled Professionals
Cardiopulmonary bypass surgeries need specialized heart surgeons, perfusionists and technicians handling pumps, oxygenators and overall system. However, many territories report an acute deficiency of such professionals due to various reasons like fewer educational opportunities, aging workforce and lack of perceived career benefits. This shortage of skilled professionals can impede hospitals from performing surgeries to their full capacity despite equipment availability. It also discourages overseas training and imports that could otherwise supplement local talent shortage.
Emergence of Affordable Healthcare Options
Various stakeholders are trying to make quality treatment cost-effective for more patients. In the medical devices sector, firms are developing low-cost cardiopulmonary bypass equipment tailored for resource-poor settings. Public-private partnerships also aim to boost local manufacturing and supply chain of such systems in developing countries. Health insurance penetration is surging due to growing awareness and government initiatives. Several emerging nations have launched universal coverage programs that may cover cardiothoracic procedures and devices. As out-of-pocket costs reduce, demand from previously underserved population segments rises rapidly. These factors point towards immense opportunities in global cardiovascular healthcare in the coming years.
Link - https://www.coherentmarketinsights.com/market-insight/cardiopulmonary-bypass-equipment-market-2026
Key Development
- On January 9, 2024, Inspira Technology, a specialty medical device company, launched a single-use disposable blood oxygenation kit. This kit, currently in development for its INSPIRA ART medical device series, is also being engineered to work seamlessly with other life support machines, including specific cardio-pulmonary bypass devices. By aiming to reduce costs and enhance efficiency in hospital budgets, this initiative represents a forward-looking approach to medical innovation.
- In March 2023, LivaNova, a medical device manufacturer, received USFDA clearance for its Essenz Heart-Lung Machine (HLM), marking the launch of the Essenz Perfusion System in the U.S. This system, inclusive of the Essenz Patient Monitor, offers a patient-specific perfusion approach driven by data, enhancing clinical workflows and patient care during cardiopulmonary bypass procedures.
Key Players: Medtronic, LivaNova, Terumo Cardiovascular Systems Corporation, Maquet Holding BV & Co. KG, Braun Melsungen AG, Medica s.p.a., Eurosets, Fresenius Medical Care AG & Co. KGaA, Lepu Medical Technology, Elite Life Care, OriGen Biomedical, Tianjin Medical, Soma Technology, Inc., Braile Biomédica, CardioGenesis Corporation (part of Philips), Century Medical, Inc., Nonin Medical, Inc., Xijian Medical
